Janux Therapeutics Announces Positive Initial Phase 1 Data For JANX011 In Healthy Volunteers, Supporting Planned Development In Patients With Autoimmune Disease
Ler o artigo completo
Tenha acesso ilimitado aos artigos da Reuters e de todas as outras fontes de notícias no TradingView.